Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ArtsyTwits
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ArtsyTwits
-
Transapical mitral valve replacement using
@AbbottNews#device in the real world. Hoping post approval ‘registry’ in Europe will become true surveillance registry to ensure long-term safety @IDEALCollab @MDEpiNet_ppphttps://www.dicardiology.com/article/worlds-first-transcatheter-mitral-valve-approved-europe …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
With survival curves that cross at 3-4yr & favoriting surgical replacement what would landmark analysis show? combined endpoints favoring surgical valve replacement. & these are mostly octogenarian patients. What would be the outcomes in younger patients?
@RFRedberg@JialinMaohttps://twitter.com/NEJM/status/1223229443813957637 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mentoring academy
@WeillCornell@WCMMentoring townhall by Dean@AugustineMKChoi and consistent and strong message to be honest with mentees! Mentoring is a challenge in modern academic medicine with few incentives- comes from the heartHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
Had a paper rejected because though I talked about differences I didn’t tell the reader which were significant. I did include CIs. Badge of honor?
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
Are there any
@Twitter lists we should follow on#SurgTech#SurgInnovation? We are looking for cutting edge surgical techniques and research. Let us know!https://twitter.com/BMJSurgTech/status/1220385648848384001 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The incurable human bias towards paying excessive attention & spending resources for new and often relatively small risk versus tackling huge existing problems-https://twitter.com/AlokPatelMD/status/1221951480900374528 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
Proud of being part of this rising new journal on innovative research in surgery!
#GermanVasc further pushes the quality improvement initiative in PAOD treatment together with@MDEpiNet_ppp@MatthiasTrenner@ArtsyTwits Read the study protocol open access! https://sit.bmj.com/content/2/1/e000020 …pic.twitter.com/KvpUh8JAUN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Never ending concerns since albumin story in high risk
#surgeryhttps://twitter.com/Tfeend/status/1221836414771482626 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
“Interoperability is essential” says
@mandl at#ONC2020, making the point that blocking interoperability is not a way to protect patients. The interoperability needs to happen, while we also work to help people safeguard their data.@ONC_HealthITHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
NHS doctors have become the first in the world to remove a cancer patient’s lung using a minimally invasive technique that left behind a scar of just 2 incheshttps://www.thetimes.co.uk/edition/news/milkman-out-of-bed-hours-after-world-first-keyhole-lung-removal-dp7kp993x?utm_medium=Social&utm_source=Twitter#Echobox=1579978233 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
thank you Dr. Aresu! Excellent- This is important case of innovation to describe for
@BMJSurgTech may need a registry to start capturing accumulated experience and at some point to compare to#thoracoscopy ?@Medtronic@MDEpiNet_ppp@NESTccMedTechhttps://twitter.com/giuseppearesu1/status/1221435594158563333 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The ‘fishnet’ used for lung removal attached to
#endoscope is a#medicaldevice and description of the#device can be helpful- is it home grown? Manufacturing needed or easy to crate from exiting products and use off-label?Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
Who should we follow in the field of
#SurgTech? Who are current innovators of devices, techniques, and ideas.@patsyllamd@HeatherEvans@UCSFSurgInnov@surgedacademy@heatheryeomd@hopkinssurgery@JeffMilsom@ArtsyTwits@DukeSurgery@FDArecalls#Surgtweeting#surgicalresearchpic.twitter.com/78seMn5tvn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
‘First-in-human’ keyhole
#surgery lung removal for#lungcancer#cancer fantastic innovation! Wish IDEAL report is written & submitted to @BMJSurgTech @giuseppearesu1 @ RoyalPapworth @IDEALCollab @BrendonStilesMDhttps://www.thetimes.co.uk/article/hours-after-world-first-keyhole-lung-removal-cancer-patient-gets-out-of-bed-dp7kp993x …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
Demonstrates the importance of coordinated registry network with
@MDEpiNet_ppp@US_FDA#SPARED@ArtsyTwits@michael_gorin@BiancoFJ_ Ronald Chen#PCCONCEPT for prospective assessment or outcomesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
We are excited to announce the launch of our twitter feed for
@BMJSurgTech -https://sit.bmj.com/Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
We have an all star cast of amazing editors from many interventional surgical fields and from across the globe.
@AWBeckMD@EBMUrology@ag_kolias@dliebesk@andrea_pusic@CharlesRardin@heatheryeomd@jdimick1@jimhumd@artsytwits@McCullochP to name a few!pic.twitter.com/91VruSOjGr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Art Sedrakyan proslijedio/la je Tweet
I am looking forward to working on this journal with
@ArtsyTwits@jdimick1@jimhumd@andrea_pusic@McCullochP@bmj_latest@bmj_company focus is on rigorous cutting edge surgical tech and development@JeffreyMilsomMD@ReemSharaihahttps://twitter.com/BMJSurgTech/status/1220346777079111681 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.